Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 7040312, 8 pages
http://dx.doi.org/10.1155/2016/7040312
Research Article

Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I

1Department of Dermatology, Faculty of Medicine, Sohag University, P.O. Box 82524, Sohag, Egypt
2Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, P.O. Box 71524, Assiut, Egypt
3Department of Biochemistry and Molecular Biology, Qena Faculty of Medicine, South Valley University, P.O. Box 83523, Qena, Egypt
4Department of Zoology, Faculty of Science, Sohag University, P.O. Box 82524, Sohag, Egypt

Received 14 July 2016; Revised 1 September 2016; Accepted 7 September 2016

Academic Editor: Michele Malaguarnera

Copyright © 2016 Hanan A. Assaf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Simpson, W. Cunliffe, T. Burns et al., “Disorders of sebaceous glands,” in Rook's Textbook of Dermatology, T. Burns, S. Breathnach, and N. Cox, Eds., pp. 43–78, Blackwell, Malden, Mass, USA, 7th edition, 2004. View at Google Scholar
  2. H. Gollnick, W. Cunliffe, D. Berson et al., “Management of acne: a report from a global alliance to improve outcomes in acne,” Journal of the American Academy of Dermatology, vol. 49, no. 1, supplement, pp. S1–S37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Z. Ghodsi, H. Orawa, and C. C. Zouboulis, “Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study,” Journal of Investigative Dermatology, vol. 129, no. 9, pp. 2136–2141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Capitanio, J. L. Sinagra, V. Bordignon, P. Cordiali Fei, M. Picardo, and C. C. Zouboulis, “Underestimated clinical features of postadolescent acne,” Journal of the American Academy of Dermatology, vol. 63, no. 5, pp. 782–788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Cowin, M. P. Brosnan, T. M. Holmes, and M. W. J. Ferguson, “Endogenous inflammatory response to dermal wound healing in the fetal and adult mouse,” Developmental Dynamics, vol. 212, no. 3, pp. 385–393, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Fabbrocini, M. C. Annunziata, V. D'Arco et al., “Acne scars: pathogenesis, classification and treatment,” Dermatology Research and Practice, vol. 2010, Article ID 893080, 13 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. C. Melnik and G. Schmitz, “Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris,” Experimental Dermatology, vol. 18, no. 10, pp. 833–841, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. W. H. Daughaday and P. Rotwein, “Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations,” Endocrine Reviews, vol. 10, no. 1, pp. 68–91, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. P. De Meyts and J. Whittaker, “Structural biology of insulin and IGF1 receptors: implications for drug design,” Nature Reviews Drug Discovery, vol. 1, no. 10, pp. 769–783, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. F. White, “IRS proteins and the common path to diabetes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 283, no. 3, pp. E413–E422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Thiboutot, “Regulation of human sebaceous glands,” Journal of Investigative Dermatology, vol. 123, no. 1, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Deplewski and R. L. Rosenfield, “Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation,” Endocrinology, vol. 140, no. 9, pp. 4089–4094, 1999. View at Google Scholar · View at Scopus
  13. D. Deplewski and R. L. Rosenfield, “Role of hormones in pilosebaceous unit development,” Endocrine Reviews, vol. 21, no. 4, pp. 363–392, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-A. Hansson, A. Nilsson, J. Isgaard et al., “Immunohistochemical localization of insulin-like growth factor I in the adult rat,” Histochemistry, vol. 89, no. 4, pp. 403–410, 1988. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. Rudman, M. P. Philpott, G. A. Thomas, and T. Kealey, “The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?” Journal of Investigative Dermatology, vol. 109, no. 6, pp. 770–777, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Baserga, A. Hongo, M. Rubini, M. Prisco, and B. Valentinis, “The IGF-I receptor in cell growth, transformation and apoptosis,” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, vol. 1332, no. 3, pp. F105–F126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Tasli, S. Turgut, N. Kacar et al., “Insulin-like growth factor-I gene polymorphism in acne vulgaris,” Journal of the European Academy of Dermatology and Venereology, vol. 27, no. 2, pp. 254–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Barreca, M. De Luca, P. Del Monte et al., “In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors,” Journal of Cellular Physiology, vol. 151, no. 2, pp. 262–268, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-H. Tsai, S.-F. Yang, Y.-J. Chen, M.-Y. Chou, and Y.-C. Chang, “The upregulation of insulin-like growth factor-1 in oral submucous fibrosis,” Oral Oncology, vol. 41, no. 9, pp. 940–946, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. T. Fawzi, S. O. Tawfik, A. M. Eissa, M. H. M. El-Komy, M. R. E. Abdel-Halim, and O. G. Shaker, “Expression of insulin-like growth factor-I in lesional and non-lesional skin of patients with morphoea,” British Journal of Dermatology, vol. 159, no. 1, pp. 86–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Hamaguchi, M. Fujimoto, T. Matsushita, M. Hasegawa, K. Takehara, and S. Sato, “Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis,” Journal of Rheumatology, vol. 35, no. 12, pp. 2363–2371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. L. Ou, B. S. Lee, L. I. Lin et al., “Vertical blockade of the IGFR-PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin,” Molecular Cancer, vol. 13, no. 2, pp. 1–11, 2014. View at Google Scholar
  23. G. Y. Kim, S.-J. Lim, and Y. W. Kim, “Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas,” Modern Pathology, vol. 24, no. 10, pp. 1336–1347, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Dallaglio, A. Marconi, and C. Pincelli, “Survivin: a dual player in healthy and diseased skin,” Journal of Investigative Dermatology, vol. 132, no. 1, pp. 18–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Ito, K. Shiraki, K. Sugimoto et al., “Survivin promotes cell proliferation in human hepatocellular carcinoma,” Hepatology, vol. 31, no. 5, pp. 1080–1085, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Fukuda and L. M. Pelus, “Survivin, a cancer target with an emerging role in normal adult tissues,” Molecular Cancer Therapeutics, vol. 5, no. 5, pp. 1087–1098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. De Minicis, E. Seki, H. Uchinami et al., “Gene expression profiles during hepatic stellate cell activation in culture and in vivo,” Gastroenterology, vol. 132, no. 5, pp. 1937–1946, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. H. Sisson, T. M. Maher, I. O. Ajayi et al., “Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts,” Advances in Bioscience and Biotechnology, vol. 3, no. 6, pp. 657–664, 2012. View at Google Scholar
  29. S. Vora, A. Ovhal, H. Jerajani, N. Nair, and A. Chakrabortty, “Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne,” British Journal of Dermatology, vol. 159, no. 4, pp. 990–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Cappel, D. Mauger, and D. Thiboutot, “Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women,” Archives of Dermatology, vol. 141, no. 3, pp. 333–338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. B. O. Saleh, “Role of growth hormone and insulin-like growth factor-I in hyperandrogenism and the severity of acne vulgaris in young males,” Saudi Medical Journal, vol. 33, no. 11, pp. 1196–1200, 2012. View at Google Scholar · View at Scopus
  32. I. Seleit, O. A. Bakry, A. G. Abdou, and A. Hashim, “Body mass index, selected dietary factors, and acne severity: are they related to in situ expression of insulin-like growth factor-1?” Analytical and Quantitative Cytology and Histology, vol. 36, no. 5, pp. 267–278, 2014. View at Google Scholar · View at Scopus
  33. D. Ben-Amitai and Z. Laron, “Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 8, pp. 950–954, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Klinger, S. Anin, A. Silbergeld, R. Eshet, and Z. Laron, “Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome,” Clinical Endocrinology, vol. 48, no. 1, pp. 81–87, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. T. M. Smith, Z. Cong, K. L. Gilliland, G. A. Clawson, and D. M. Thiboutot, “Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1,” Journal of Investigative Dermatology, vol. 126, no. 6, pp. 1226–1232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. B. C. Melnik, “FoxO1—the key for the pathogenesis and therapy of acne?” Journal of the German Society of Dermatology, vol. 8, no. 2, pp. 105–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. B. C. Melnik, “Evidence for acne-promoting effects of milk and other insulinotropic dairy products,” Nestlé Nutrition Workshop Series: Pediatric Program, vol. 67, pp. 131–145, 2011. View at Google Scholar
  38. P. M. Krein and B. W. Winston, “Roles for insulin-like growth factor I and transforming growth factor-β in fibrotic lung disease,” Chest, vol. 122, no. 6, supplement, pp. 289S–293S, 2002. View at Google Scholar · View at Scopus
  39. D. Thiebaud, K. W. Ng, D. M. Findlay, M. Harker, and T. J. Martin, “Insulinlike growth factor 1 regulates mRNA levels of osteonectin and Pro-α1(I)-collagen in clonal preosteoblastic calvarial cells,” Journal of Bone and Mineral Research, vol. 5, no. 7, pp. 761–767, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Rothe, R. D. Altman, and V. Falanga, “Plasma somatomedin-C levels in systemic sclerosis,” British Journal of Dermatology, vol. 119, no. 5, pp. 639–642, 1988. View at Publisher · View at Google Scholar · View at Scopus
  41. A. R. Bowen, A. N. Hanks, K. J. Murphy, S. R. Florell, and D. Grossman, “Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias,” American Journal of Dermatopathology, vol. 26, no. 3, pp. 177–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. K. B. Calder, F. K. Khalil, S. Schlauder, H. D. Cualing, and M. B. Morgan, “Immunohistochemical expression of survivin in cutaneous sebaceous lesions,” The American Journal of Dermatopathology, vol. 30, no. 6, pp. 545–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Marsillach, N. Ferré, J. Camps, A. Rull, R. Beltran, and J. Joven, “Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats,” Molecular and Cellular Biochemistry, vol. 308, no. 1-2, pp. 101–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Guha and D. C. Altieri, “Survivin as a global target of intrinsic tumor suppression networks,” Cell Cycle, vol. 8, no. 17, pp. 2708–2710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Guha, J. Plescia, I. Leav, J. Li, L. R. Languino, and D. C. Altieri, “Endogenous tumor suppression mediated by PTEN involves survivin gene silencing,” Cancer Research, vol. 69, no. 12, pp. 4954–4958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. B. C. Melnik, “Acne vulgaris: an inflammasomopathy of the sebaceous follicle induced by deviated FoxO1/mTORC1 signalling,” British Journal of Dermatology, vol. 174, no. 6, pp. 1186–1188, 2016. View at Publisher · View at Google Scholar
  47. G. Monfrecola, S. Lembo, G. Caiazzo et al., “Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin,” Experimental Dermatology, vol. 25, no. 2, pp. 153–155, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. N. F. Agamia, D. M. Abdallah, O. Sorour, B. Mourad, and D. N. Younan, “Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet,” British Journal of Dermatology, vol. 174, no. 6, pp. 1299–1307, 2016. View at Publisher · View at Google Scholar
  49. K. Song, E. Shankar, J. Yang et al., “Critical role of a survivin/TGF-beta/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells,” PLoS ONE, vol. 8, no. 5, Article ID e61896, 14 pages, 2013. View at Publisher · View at Google Scholar
  50. C. C. Zouboulis, E. Jourdan, and M. Picardo, “Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions,” Journal of the European Academy of Dermatology and Venereology, vol. 28, no. 5, pp. 527–532, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Nelson, Z. Cong, K. L. Gilliland, and D. M. Thiboutot, “TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells,” British Journal of Dermatology, vol. 165, no. 3, pp. 526–533, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. B. C. Melnik, “Pro-inflammatory sebocyte growth and survival signalling in acne vulgaris are reversed by pro-apoptotic isotretinoin signalling,” Experimental Dermatology, vol. 25, no. 9, pp. 676–677, 2016. View at Publisher · View at Google Scholar